According to the results of a new study published in the Journal of Applied Microbiology, several cannabinoids, including CBN, THC, CBG, CBC, and CBD, demonstrate significant activity against methicillin-resistant Staphylococcus aureus (MRSA) biofilms, a major source of hospital-acquired pneumonia.
Researchers evaluated the five main phytocannabinoids for their effects on MRSA biofilms using crystal violet staining, resazurin metabolic assay, reactive oxygen species (ROS) analysis, and propidium iodide membrane integrity testing. The minimum inhibitory concentrations for each compound were between 1–2 µg/mL, indicating strong antibacterial potential.
Cannabinol (CBN) stood out as the most effective, substantially reducing MRSA biofilm mass and bacterial survival while also producing the highest levels of ROS within the bacteria. Cannabidiol (CBD), while less effective overall, caused the greatest disruption to bacterial membranes. The remaining cannabinoids, including THC, CBG, and CBC, also showed notable but varying degrees of anti-biofilm activity.
The findings highlight that cannabinoids, though chemically related, act through different mechanisms in disrupting MRSA biofilms.
The authors conclude by stating “This study showed that despite being chemically similar, the cannabinoids demonstrated different potency and potentially different mechanisms of action against MRSA. More research is needed to investigate how they act on this pathogen and its biofilm.”
More articles from The Marijuana Herald:
